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Accepted 17 October 2011AbstractObjective: The aim of this study was to investigate simultaneous laparoscopy in endometriotic women with infertility undergoing in vitro
fertilization (IVF).
Materials and Methods: Forty-seven infertile patients with endometriosis were enrolled in this retrospective study and underwent IVF cycles in
a university affiliated hospital.
Results: The chemical pregnancy, clinical pregnancy and live birth rates were statistically significantly different between patients with minimal
or mild stage endometriosis and patients with moderate or severe stage endometriosis, who received simultaneous laparoscopy and modified IVF
with a GnRH antagonist protocol. A higher live birth rate was achieved in IVF patients with minimal or mild stage endometriosis combined with
laparoscopic treatment, than in patients who received traditional IVF with prior laparoscopic surgery for endometrioma.
Conclusion: Simultaneous laparoscopy combined with a modified IVF (GnRH antagonist) protocol may benefit patients with minimal and mild
endometriosis. Traditional GnRH agonist IVF cycles may improve the fecundity rates in women with moderate and severe endometriosis after
laparoscopic treatment.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Endometriosis affects approximately 10e20% of women of
reproductive age, while among infertile women, the preva-
lence is estimated to range between 30% and 50% [1]. With
the recent advance of ultrasonography [2,3], ultrasound
examination is useful in the differential diagnosis and in
planning medical or surgical intervention for endometriosis.
Medical treatment with gonadotropin-releasing hormone
(GnRH) agonists prior to in vitro fertilization (IVF) cycles is
associated with an increase in pregnancy rate, but clinical* Corresponding author. Department of Obstetrics and Gynecology, National
Cheng Kung University Hospital and College of Medicine, 138 Sheng-Li
Road, Tainan 70428, Taiwan.
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doi:10.1016/j.tjog.2012.01.013therapy alone is considered insufficient for treating
endometriosis-associated infertility [4]. The surgical purposes
for patients suffering from endometriosis are to confirm the
pathohistology and severity of the involved area, and to relieve
the symptoms, such as dysmenorrhea and pelvic pain [5].
Besides, we need to exclude the possibility of malignancy in
cases with endometrioma > 3 cm [3,6]. Laparoscopy remains
the gold standard for treatment of endometriosis, as it can
coagulate all visible endometriotic lesions and excise associ-
ated pelvic or visceral adhesion by using the see and treat
method [7]. It serves as a less invasive and cost effective
approach, when compared to laparotomy, for endometriosis
surgery. Laparoscopic surgery also diminishes the cost,
morbidity and the recurrence rate of postoperative pelvic
adhesions.cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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replaced with a more evidence-based approach, that tries to
balance carefully the advantages as well as the complications
of cyst removal prior to an IVF cycle [1]. The benefits of
surgical therapy for infertility associated with endometriosis
have been well documented [8e11]. Laparoscopic surgery
before IVF cycles, not only offers the advantage of making
a decision about the treatment course, but also for establishing
a good pelvic environment to enhance pregnancy during IVF
cycles in infertility treatment in patients with ovarian endo-
metriomas [12,13]. Recently, with the advent of IVF, the
number of patients undergoing diagnostic laparoscopic eval-
uation as part of the initial workup has decreased. Owing to
the high rates of recurrence (approximately 50% after 5 years
of therapy cessation) [14e17], we are frequently presented
with a dilemma between performing IVF, or adopting
a surgical approach, as the first choice to achieve better results
when treating an infertile couple. Most published data is in
favor of the hypothesis that laparoscopic surgical removal of
ovarian endometrioma prior to IVF does not offer any addi-
tional benefit in terms of fertility outcomes [18,19], but may
decrease the ovarian response to gonadotropins. The presence
of endometriomas does not obviously affect the ovarian
response to hyperstimulation in endometriotic women during
IVF treatment. In addition, the pregnancy rate, following
combined treatment with laparoscopy and subsequent IVF,
in women with endometriosis associated infertility, is higher
than that following no treatment, surgery or IVF alone [20].
The aim of this study is to display the therapeutic effect of
simultaneous laparoscopic surgery for endometriosis-
associated infertility during IVF treatment.Fig. 1. Oocyte retrieval with the aid of laparoscopy in women with
endometriosis.Materials and methods
This study was approved by the Institutional Review Board
of National Cheng Kung University Hospital. Forty-seven
infertile patients, who received laparoscopic surgery for
endometriosis and/or endometrioma, were enrolled retro-
spectively through our IVF database system from January
2004 through January 2008. The inclusion criteria were: (1)
symptoms of endometriosis and/or endometrioma; (2) history
of laparoscopic surgery for endometriosis and/or endome-
trioma; and (3) histologically confirmed diagnosis of endo-
metriosis and/or endometrioma. Patients who received
exploratory laparotomy for endometriosis and/or endome-
trioma were excluded. Surgical treatment consisted of thor-
ough laparoscopic electrocauterization/ablation or excision of
all peritoneal and nonperitoneal endometriotic lesions, lysis of
adhesions, and appropriate management of ovarian endome-
triomas. Our patients were classified into 2 groups. Group 1
consisted of 23 patients with clinical symptoms of endome-
triosis and/or endometrioma, who received laparoscopic
surgery with a modified IVF (GnRH antagonist) protocol at
the same time (on the day of oocyte retrieval). Group 2 con-
sisted of 24 patients with a previous history of laparoscopic
surgery for endometrioma. After laparoscopic surgery (at least3 months later), they tried to conceive through the traditional
IVF treatment with a GnRH agonist protocol.
In our GnRH antagonist protocol, each patient received
exogenous gonadotropins starting on the 2nd day of menstru-
ation, and later, 0.25 mg/day of cetrorelix (Cetrotide, ASTA
Medica, Halle, Germany; Baxter Oncology, GmbH, Germany)
was administered subcutaneously, when the leading follicle
reached 14 mm in diameter, until the human chorionic
gonadotropin (hCG) injection. Patients who received the
GnRH agonist protocol, were treated with 1 mg/day leuprolide
(LEUprolide acetate; FAMAR L’AIGLE, Saint Remy Sur
Avre, France) starting on the 21st day prior to menstruation for
pituitary desensitization. When exogenous gonadotropins were
started on day 2 of menstruation, the dose of leuprolide was
decreased to 0.5 mg/day. It was administered daily until the
day before recombinant hCG (Ovitrelle; Merck Serono S.P.A.,
Modugno, Italy) injection. Additional doses of recombinant
gonadotropin, including recombinant FSH (Industria Farm-
aceutica Serono S.P.A., Modugno, Italy) and lutropin alfa
(Luveris; Serono, Switzerland), were given to patients in each
group if necessary. The FSH dose was adjusted individually,
according to the response of the ovaries and serum estradiol
concentrations. The cycles were cancelled when estradiol
showed a plateau or decreased level, LH was > 12.1 mIU/mL,
or progesterone was > 1.7 ng/mL during ovarian stimulation.
When the leading follicle reached 18 mm in diameter, or at
least two follicles were > 17 mm in diameter, 250 mg of
recombinant hCG was administered subcutaneously. Either
laparoscopic (Fig. 1) or transvaginal oocyte retrieval was
performed 34e36 hours later. Embryos were cultured and
transferred transvaginally on day 2e3 after oocyte retrieval.
The luteal phase was supported with micronized vaginal
progesterone, 600 mg/day, until the 10th week of gestation, in
cases where a pregnancy was achieved.
Data regarding patient demographics, including age, parity,
the numbers of oocytes retrieved, the numbers of embryos
transferred, and the stages of endometriosis, were recorded in
our retrospective study. The severity of endometriosis was
classified into minimal, mild, moderate and severe stages
according to the American Society for Reproductive Medicine
(ASRM) revised classification of endometriosis. Positive
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mL. Clinical pregnancy is defined as the presence of a positive
fetal heart beat detected by sonography. Live birth is defined
as a live baby delivered after 24 weeks gestational age.
The statistical analyses were performed using the Statistics
Package for Social Science version 11.0 (SPSS Inc., Chicago,
IL, USA). The differences in the age, numbers of oocytes
retrieved and the numbers of embryos transferred between the
endometriosis study groups, were examined by the Student t test.
The Fisher’s exact test was used to analyze the pregnancy
outcome amongst these two groups. Statistical significance was
defined as p < 0.05. The power for detecting the statistical
significance of live birth rate between minimal or mild (early-
staged) andmoderate or severe (advanced-staged) endometriosis
is 0.67563. The power between minimal or mild (early-staged)
endometriosis and IVF with previous laparoscopy for endome-
triosis is 0.66937 for live birth rate.
Results
In group 1, 23 patients (mean age ¼ 34.78  3.80 years;
average numbers of oocytes retrieved ¼ 5.09  4.65, average
numbers of embryos transferred ¼ 1.94  0.77) who under-
went a total of 23 assisted reproduction cycles, were recruited.
These patients received laparoscopic surgery and IVF treat-
ment at the same time. In group 2, 24 patients (mean
age ¼ 34.83  4.33 years; average numbers of oocytes
retrieved ¼ 6.44  5.14, average numbers of embryos
transferred ¼ 2.04  0.98) who underwent a total of 27 IVF
cycles, were recruited. No statistical significance was noted
between the two study groups regarding age, numbers of
oocytes retrieved and the numbers of embryos transferred
(Table 1).
Table 2 shows the results of pregnancy outcome in both
groups. In group 1, 9 patients were diagnosed with minimal to
mild endometriosis. Our results of the chemical pregnancy,
clinical pregnancy and live birth rates obtained from these
patients were 66.67%, 55.56% and 55.56%, respectively.
Amongst the remaining 14 patients diagnosed with moderate
and severe stage endometriosis, only one subject conceived
successfully, and the results of the chemical pregnancy, clin-
ical pregnancy and live birth rates obtained from these patients
were all 7.14%. In group 2, 24 patients with endometriosis
(post status laparoscopic surgery for endometrioma) received
a total of 27 IVF cycles. Results for the chemical pregnancy,Table 1
Comparison of demographic data between IVF þ simultaneous laparoscopic
treatment and IVF þ previous laparoscopy in women with endometriosis.
IVF þ simultaneous
laparoscopy for
endometriosis
IVF þ previous
laparoscopy for
endometriosis
p
Patient no. 23 24
Cycle 23 27
Age (yr) 34.78  3.80 34.83  4.33 0.966
Egg no. 5.09  4.65 6.44  5.14 0.336
Embryo transfer (ET) no. 1.94  0.77 2.04  0.98 0.730clinical pregnancy and live birth rates obtained from these
patients were 37.04%, 25.93% and 14.81%, respectively.
If we further compared the results obtained from Table 2,
a statistically significant difference ( p 0.005) was noted in
the chemical pregnancy rate between patients with minimal or
mild stage endometriosis (66.67%, 6/9 patients) and patients
with moderate or severe stage endometriosis (7.14%, 1/14
patients) in group 1 patients. The clinical pregnancy rate and
live birth rate between these two groups also showed statisti-
cally significant differences ( p ¼ 0.018). If we compared the
results of live birth rate between patients with minimal or mild
stage endometriosis (66.67%, 6/9 patients) and patients with
prior laparoscopic surgery for endometrioma, a higher live
birth rate was achieved in group 1 patients with minimal or
mild stage endometriosis ( p ¼ 0.026). Although the values of
power calculation in live birth rates were both less than 0.8,
statistically significant differences were noted from the above
data.
Discussion
Endometriosis is considered to be a polygenic disease with
a complex, multifactorial etiology [21]. Several studies have
examined the association of endometriosis and implantation
failure on a molecular level. These basic science studies
suggest that endometriosis may be involved in the deregula-
tion of selective genes which play critical roles in the process
of implantation [22,23]. The optimal approach is to reduce
inflammation in the pelvis, annihilate any adverse factors
leading to endometriosis, and consider surgical treatment of
endometriotic lesions, in order to create a conception friendly
environment resulting in enhanced uterine receptivity.
The influence of endometriosis on IVF and the manage-
ment before IVF remain controversial. The fertilization rate is
reduced in endometriotic women with early stages (stage I and
II), which may be due to a hostile microenvironment [24].
Poor IVF outcome is seen in endometriotic women with
advanced stages (stage III and IV). In our study, patients with
minimal or mild stage endometriosis, who received laparo-
scopic surgery together with IVF treatment simultaneously,
had higher pregnancy rates than patients who suffered from
moderate or severe stage endometriosis. Our study showed
that patients who received laparoscopic surgery for endome-
trioma, followed by IVF treatment (group 2), usually suffered
from moderate or severe stage endometriosis. Although
different IVF stimulation protocols were used in our study,
when comparing patients in group 2 with those moderate or
severe stage endometriosis patients who received laparoscopic
surgery together with IVF treatment in group 1, there was no
difference in the pregnancy outcome between those two
groups. However, when compared with patients in group 2,
group 1 patients who suffered from minimal or mild stage
endometriosis and received laparoscopic surgery and IVF
treatment simultaneously, had higher live birth rates. There are
comparable clinical outcomes for the GnRH antagonist and
long GnRH agonist protocols for IVF treatment [25]. The use
of antagonist protocols is associated with a reduction in
Table 2
Comparison of in vitro fertilization outcomes between IVF þ simultaneous laparoscopic treatment and IVF þ previous laparoscopy in women with endometriosis.
IVF þ simultaneous laparoscopy for endometriosis IVF þ previous laparoscopy
for endometriosis
Minimal or mild Moderate or severe
Chemical pregnancy rate 66.67 % (6/9)* 7.14% (1/14) 37.04% (10/27)
Clinical pregnancy rate 55.56 % (5/9)* 7.14% (1/14) 25.93% (7/27)
Live birth rate 55.56% (5/9)* 7.14% (1/14) 14.81% (4/27)
*Fisher’s exact test, p < 0.05.
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live-birth rates. In addition, the pregnancy outcome may
further improve by frozen embryo strategy, to offer better
endometrial environment for implantation [26]. In patients
with moderate or severe stage endometriosis in group 1, the
embryo may be frozen after confirmation of fertilization.
Because there is no significant difference in implantation or
pregnancy rate of frozen thawed embryo transfer cycles
following previous IVF GnRH agonist or antagonist stimula-
tion [27], they could only stop embryo transfer in the fresh
cycle and wait for the next suitable cycle to improve preg-
nancy outcome.
Laparoscopic surgery is indicated for infertile women with
ovarian endometriomas with preservation of the normal
residual ovarian cortex. Laparoscopic endometrioma cys-
tectomy reduces the ovarian reserve, but does not impair the
pregnancy outcome [28]. A reduced follicular response, in
natural and clomiphene-stimulated cycles, has been shown in
younger women after ovarian cystectomy for endometriomas,
but can be recovered with gonadotropin stimulation [29]. In
patients with advanced stages of endometriosis, a significantly
poorer IVF outcome has been demonstrated as compared to
those patients with tubal infertility [30]. Our previous study
found that there were lower indices of intraovarian blood flow
in endometriosis patients during IVF using power Doppler
ultrasound analysis. The decreased ovarian vascularity in the
ovarian endometrioma group, may be ascribed to intra-
operative ovarian damage [31]. Surgery should be envisaged
only in the presence of large cysts (balancing the threshold to
operate with the cyst location within the ovary), or to treat
concomitant pain symptoms which are refractory to medical
treatments, or when malignancy cannot reliably be ruled out
[18]. In addition, the experience of the laparoscopist may
affect ovarian reserve in infertile women who previously
underwent laparoscopic treatment for endometriomas, which
leads to decreased antral follicle count number and live birth
rate during IVF treatment [32].
Differences in the financial budget of medical insurances
exist in different countries. The cost of operations is always
expensive. It is also hard to classify the stage of endometri-
osis without further surgical intervention. In Taiwan, the cost
of laparoscopic treatment for endometriosis is covered by
National Health Insurance of the Republic of China. Thus, it
is indeed cost effective and beneficial to perform laparoscopic
surgery with modified IVF therapy simultaneously, as shown
in the live birth rate results of our group 1 patients with
minimal or mild stage endometriosis. In this study, weattempted to overcome the obstacles of decreased ovarian
reserve, ovarian response and increased morbidity in patients
with ovarian endometrioma related infertility, via performing
laparoscopic surgery and modified IVF treatment simulta-
neously. The pregnancy outcome did not demonstrate
a significant difference between traditional IVF treatment in
endometriotic women after laparoscopy and modified IVF
with laparoscopy for ovarian endometrioma, although the
traditional IVF GnRH protocol showed higher pregnancy
rates. Therefore, individualized IVF protocols are tailored
according to the patient’s age, etiology of infertility (endo-
metriosis related), duration, type and the results of previous
IVF protocols. The optimal approach in managing an infertile
endometriosis patient, is to perform a comprehensive
evaluation, and then develop a treatment protocol that is
individualized for each patient starting from a simple, safe,
cost-effective treatment to a sophisticated and expensive
treatment.
In conclusion, traditional GnRH agonist IVF protocols may
assist in the pregnancy rates of women who suffer from
moderate and severe endometriosis, confirmed from previous
laparoscopic surgery. For those patients with minimal and
mild endometriosis, laparoscopic surgery, combined with
modified GnRH antagonist IVF cycles, would improve preg-
nancy rates, decrease morbidity and reduce unnecessary
medical costs. In addition, it will shorten the time to
conception, which is the optimal goal for an infertile couple
and the surgeon. In our pioneer study, innovative protocols
were applied in order to demonstrate the differences in
fecundity rate in endometriosis-associated female infertility
via a similar treatment strategy, but adjusted order of events in
the treatment protocol. One shortcoming in our study was the
limited number of patient. Further multicenter, randomized,
clinical trials regarding this issue should be undertaken.References
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